Is VIVS or VNDA more undervalued in 2026?

CirclFi compares VivoSim Labs, Inc. (VIVS) and Vanda Pharmaceuticals Inc. (VNDA) using 13 institutional-grade valuation models. VIVS has a Quality of Company score of 4.5/10 while VNDA scores 6.3/10.

Which is a better buy — VIVS or VNDA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do VIVS and VNDA valuations compare?

VIVS at $1.31 and VNDA at $6.64 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

VIVS vs VNDA Valuation Comparison 2026 — Intrinsic Value Analysis

VIVS

Biotechnology

VivoSim Labs, Inc.

Quality

4.5

out of 10

Value Trap

LOW

Price

$1.31

Last close

Models

10/13

Active

VNDA

Biotechnology

Vanda Pharmaceuticals Inc.

Quality

6.3

out of 10

Value Trap

LOW

Price

$6.64

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	VIVS Fair Value	VIVS Upside	VNDA Fair Value	VNDA Upside
Bayesian DCF	Intrinsic	$1.03	-21.2%	$4.15	-37.6%
Earnings Power Value	Intrinsic	$3.09	+114.7%	—	—
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.52	-61.3%	$0.57	-91.9%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for VIVS vs VNDA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

VIVS vs VNDA — Which Stock Is More Undervalued?

VNDA scores higher with a 6.3/10 quality rating vs VIVS's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing VivoSim Labs, Inc. (VIVS) and Vanda Pharmaceuticals Inc. (VNDA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

VIVS currently trades at $1.31 with a QOC of 4.5/10, while VNDA trades at $6.64 with a QOC of 6.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).